{
    "eid": "2-s2.0-85082147518",
    "title": "Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic",
    "cover-date": "2020-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "Coronavirus",
        "Covid-19",
        "Immune evasion",
        "Immune response",
        "Immunopathology"
    ],
    "authors": [
        "Eakachai Prompetchara",
        "Chutitorn Ketloy",
        "Tanapat Palaga"
    ],
    "citedby-count": 1104,
    "ref-count": 52,
    "ref-list": [
        "A new coronavirus associated with human respiratory disease in China",
        "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
        "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster",
        "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia",
        "Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany",
        "Factors that make an infectious disease outbreak controllable",
        "Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020",
        "Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding",
        "Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China",
        "Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020",
        "Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study",
        "Pandemic potential of 2019-nCoV",
        "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study",
        "Lung pathology of fatal severe acute respiratory syndrome",
        "MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile",
        "Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome",
        "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
        "A Novel Coronavirus from Patients with Pneumonia in China, 2019",
        "Immunopathogenesis of coronavirus infections:Implications for SARS",
        "SARS and MERS:Recent insights into emerging coronaviruses",
        "Pathogenic human coronavirus infections:Causes and consequences of cytokine storm and immunopathology",
        "Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response",
        "Middle East respiratory syndrome",
        "T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV",
        "Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome",
        "T cell responses to whole SARS coronavirus in humans",
        "Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection",
        "Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses",
        "Incubation periods of acute respiratory viral infections: A systematic review",
        "Modulation of the immune response by Middle East respiratory syndrome coronavirus",
        "Innate Immune Evasion by Human Respiratory RNA Viruses",
        "Distinct immune response in two MERS-CoV-infected patients: Can we go from bench to bedside?",
        "Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein",
        "The spike protein of SARS-CoV--a target for vaccine and therapeutic development",
        "Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model",
        "Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine -Preliminary Report",
        "mRNA vaccines - a new era in vaccinology",
        "mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases",
        "mRNA vaccine delivery using lipid nanoparticles",
        "Fast-Track Zika Vaccine Development - Is It Possible?",
        "From SARS to MERS, Thrusting Coronaviruses into the Spotlight",
        "Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome -Coronavirus",
        "Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}